These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 36584499)
1. PI3K/AKT/mTOR signaling pathway modulation by circular RNAs in breast cancer progression. Karami Fath M; Akhavan Masouleh R; Afifi N; Loghmani S; Tamimi P; Fazeli A; Mousavian SA; Falsafi MM; Barati G Pathol Res Pract; 2023 Jan; 241():154279. PubMed ID: 36584499 [TBL] [Abstract][Full Text] [Related]
2. The emerging role of noncoding RNAs in the PI3K/AKT/mTOR signalling pathway in breast cancer. Abu-Alghayth MH; Khan FR; Belali TM; Abalkhail A; Alshaghdali K; Nassar SA; Almoammar NE; Almasoudi HH; Hessien KBG; Aldossari MS; Binshaya AS Pathol Res Pract; 2024 Mar; 255():155180. PubMed ID: 38330621 [TBL] [Abstract][Full Text] [Related]
3. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer. Xu JH; Wang Y; Xu D Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012 [TBL] [Abstract][Full Text] [Related]
4. Circular RNA nuclear receptor interacting protein 1 promoted biliary tract cancer epithelial-mesenchymal transition and stemness by regulating the miR-515-5p/AKT2 axis and PI3K/AKT/mTOR signaling pathway. Gao X; Yu S; Liu S; Zhang S; Sha X; Sun D; Jiang X Environ Toxicol; 2023 Nov; 38(11):2632-2644. PubMed ID: 37466171 [TBL] [Abstract][Full Text] [Related]
5. Circular RNA hsa_circ_0010882 promotes the progression of gastric cancer via regulation of the PI3K/Akt/mTOR signaling pathway. Peng YK; Pu K; Su HX; Zhang J; Zheng Y; Ji R; Guo QH; Wang YP; Guan QL; Zhou YN Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1142-1151. PubMed ID: 32096170 [TBL] [Abstract][Full Text] [Related]
6. Clinical Diagnostic Value of circ-ARHGER28 for Breast Cancer and its Effect on MCF 7 Cell Proliferation and Apoptosis. Tao X; Na LI; Hu EX; Wang J; Wu LG; Zhang XU; Wang LB Anticancer Res; 2024 Jul; 44(7):2877-2886. PubMed ID: 38925846 [TBL] [Abstract][Full Text] [Related]
7. Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression. Xue C; Li G; Lu J; Li L Signal Transduct Target Ther; 2021 Nov; 6(1):400. PubMed ID: 34815385 [TBL] [Abstract][Full Text] [Related]
8. LncRNA MALAT1 Expression Regulates Breast Cancer Progression via PI3K/AKT/mTOR Pathway Modulation. Naveed M; Malik A; Anjum H; Ijaz B Biochem Genet; 2024 Oct; 62(5):3421-3438. PubMed ID: 38110774 [TBL] [Abstract][Full Text] [Related]
9. Circular RNA Circ_0000442 acts as a sponge of MiR-148b-3p to suppress breast cancer via PTEN/PI3K/Akt signaling pathway. Zhang XY; Mao L Gene; 2021 Jan; 766():145113. PubMed ID: 32891771 [TBL] [Abstract][Full Text] [Related]
10. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway. Wang J; Jiang C; Li N; Wang F; Xu Y; Shen Z; Yang L; Li Z; He C Cell Death Dis; 2020 Aug; 11(8):682. PubMed ID: 32826876 [TBL] [Abstract][Full Text] [Related]
11. The circular RNA hsa-circ-0072309 plays anti-tumour roles by sponging miR-100 through the deactivation of PI3K/AKT and mTOR pathways in the renal carcinoma cell lines. Chen T; Shao S; Li W; Liu Y; Cao Y Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3638-3648. PubMed ID: 31456425 [No Abstract] [Full Text] [Related]
12. Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling. Li H; Xu W; Xia Z; Liu W; Pan G; Ding J; Li J; Wang J; Xie X; Jiang D Aging (Albany NY); 2021 Jan; 13(3):4522-4551. PubMed ID: 33495420 [TBL] [Abstract][Full Text] [Related]
13. Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer. Wen W; Li Y; Cao X; Li Y; Liu Z; Tang Z; Xie L; He R Clin Breast Cancer; 2024 Aug; 24(6):e429-e451. PubMed ID: 38553373 [TBL] [Abstract][Full Text] [Related]
14. Exploring the dual role of circRNA and PI3K/AKT pathway in tumors of the digestive system. Li P; Huang D; Gu X Biomed Pharmacother; 2023 Dec; 168():115694. PubMed ID: 37832407 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway. Liu W; Zhan J; Zhong R; Li R; Sheng X; Xu M; Lu Z; Zhang S Technol Cancer Res Treat; 2021; 20():1533033821990074. PubMed ID: 33641529 [TBL] [Abstract][Full Text] [Related]
16. CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer. Jiang T; Wang H; Liu L; Song H; Zhang Y; Wang J; Liu L; Xu T; Fan R; Xu Y; Wang S; Shi L; Zheng L; Wang R; Song J Mol Cancer; 2021 Dec; 20(1):167. PubMed ID: 34922544 [TBL] [Abstract][Full Text] [Related]
17. CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis. Xu H; Liu Y; Cheng P; Wang C; Liu Y; Zhou W; Xu Y; Ji G J Exp Clin Cancer Res; 2020 Dec; 39(1):283. PubMed ID: 33317596 [TBL] [Abstract][Full Text] [Related]
18. Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Yu L; Wei J; Liu P Semin Cancer Biol; 2022 Oct; 85():69-94. PubMed ID: 34175443 [TBL] [Abstract][Full Text] [Related]
19. CircTRIM1 encodes TRIM1-269aa to promote chemoresistance and metastasis of TNBC via enhancing CaM-dependent MARCKS translocation and PI3K/AKT/mTOR activation. Li Y; Wang Z; Yang J; Sun Y; He Y; Wang Y; Chen X; Liang Y; Zhang N; Wang X; Zhao W; Hu G; Yang Q Mol Cancer; 2024 May; 23(1):102. PubMed ID: 38755678 [TBL] [Abstract][Full Text] [Related]
20. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells. Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]